RTA 402
Sponsors
M.D. Anderson Cancer Center, Biogen, Kyowa Kirin Co., Ltd.
Conditions
Chronic Kidney DiseaseLiver DiseaseLymphoid MalignanciesSolid TumorsType 2 Diabetes
Phase 1
RTA 402 in Advanced Solid Tumors or Lymphoid Malignancies
CompletedNCT00508807
Start: 2006-04-30End: 2009-12-31Updated: 2012-07-30
Study to Assess the Safety, Tolerability, and Pharmacodynamics of RTA 402 in Patients With Hepatic Dysfunction
TerminatedNCT00550849
Start: 2007-04-30End: 2007-11-30Updated: 2025-05-30
Phase 2
A Glomerular Filtration Rate (GFR) Measuring Study of RTA 402 in Chronic Kidney Disease (CKD) Patients With Type 2 Diabetes Mellitus
TerminatedNCT01572610
Start: 2012-02-29End: 2013-11-30Updated: 2017-03-03
A Study of RTA 402 in Chronic Kidney Disease (CKD) Patients With Type 2 Diabetes Mellitus
TerminatedNCT01574365
Start: 2012-02-29End: 2013-11-30Updated: 2017-03-03
The Phase II Study of Bardoxolone Methyl in Patients With Chronic Kidney Disease and Type 2 Diabetes; TSUBAKI Study
CompletedNCT02316821
Start: 2014-12-31End: 2017-09-30Updated: 2017-10-27